3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
7
Barrett Esophagus
7
Gastritis
5
Breast Neoplasms
4
Stomach Ulcer
3
Peptic Ulcer
3
Gastroesophageal Reflux
3
Dyspepsia
3
Zollinger-Ellison Syndrome
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Vomiting
1
Radiation Esophagitis
1
Precancerous Conditions
1
Peptic Ulcer Hemorrhage
1
Neoplasms
1
Neoplasm Metastasis
1
Nausea
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Hot Flashes
1
Hemorrhage
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer
1
Esophagitis, Peptic
1
Esophagitis
1
Dysbiosis
1
Colonic Neoplasms
1
Interventions
Peripheral Blood Stem Cell Transplantation
9
Cyclophosphamide
9
Biopsy
8
fludarabine phosphate
7
Whole-Body Irradiation
6
Tacrolimus
5
Mycophenolic Acid
5
Epoetin Alfa
5
Colposcopy
5
Celecoxib
5
Busulfan
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Methotrexate
4
Melphalan
4
Cyclosporine
4
Cetuximab
4
Antilymphocyte Serum
4
Polymerase Chain Reaction
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Gene Expression Profiling
3
Etoposide
3
Eflornithine
3
Darbepoetin alfa
3
Carboplatin
3
Aspirin
3
fludarabine
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Precancerous Conditions
×
Esomeprazole
×
Clear all
NCT00357682
2025-05-01
AspECT
University of Oxford
Phase 3
Completed
2,557 enrolled
17 charts